Emily Joyce, M.D.

  • Assistant Professor

Dr. Emily Joyce is a faculty member in the Division of Pediatric Nephrology and is part of the Center for Critical Care Nephrology (C3N). C3N strives to promote a multi-professional model of basic, translational, and clinical research with the goal of developing novel treatments and disruptive innovations to prevent, manage, and cure acute disorders of kidney function, as well as fluid and electrolyte disorders in critically ill patients.

C3N Website

Education & Training

  • MD: Case Western Reserve University School of Medicine Cleveland, OH
  • Residency: University of Pittsburgh School of Medicine Pittsburgh, PA
  • Fellowships: University of Pittsburgh School of Medicine Pittsburgh, PA

Representative Publications

Joyce EL, DeAlmeida DR, Fuhrman DY, Priyanka P, Kellum JA. eResearch in Acute Kidney Injury: A Primer for Electronic Health Record Research. Nephrol Dial Transplant 2018, Mar 30. ePub ahead of print.

Joyce EL, Kane-Gill SL, Fuhrman DY, Kellum JA. Drug-Associated Acute Kidney Injury: Who’s at Risk? Pediatr Nephrol 2017; 32(1):59-69.

Research Interests

Dr. Joyce's research is focused on identifying medications and medication combinations that contribute to the development of acute kidney injury (AKI) in critically ill children. For much of her research, she utilizes a large database (Peds HiDenIC) that she generated as a fellow and continues to maintain as a faculty member. The overall goal of her research is to understand the risk for, and consequences of, medication-associated AKI. She is dedicated to following children who had an episode of AKI while in the intensive care unit and monitoring them for signs of chronic kidney disease in subsequent years. Dr. Joyce is hopeful that if we detect signs of chronic kidney disease early, we will be able to intervene and prolong the kidney health of at-risk children.

Dr. Joyce is also working on the development of an AKI Alert for our electronic health record, participated in a multi-center study assessing long-term outcomes of children with nephropathic cystinosis, and in the process of collaborating with other divisions within the Department of Pediatrics to utilize the Peds HiDenIC database for additional research.